SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Johnson & Johnson Analysis Projects Lower Impella Costs Than Balloon Pump

An analysis projects lower healthcare costs with Impella than with an intra-aortic balloon pump in patients with heart failure.

JNJ

Related stories